Someit Sidhu
Gründer bei ZURA BIO LIMITED
Vermögen: 41 Mio $ am 30.04.2024
Profil
Dr. Someit Sidhu, MD, is a Non-Independent Director at Zura Bio Ltd., a Chief Executive Officer at Akaza Bioscience Ltd., a Chief Executive Officer at Izana Bioscience Ltd., a Chairman & Chief Executive Officer at JATT Ventures LP and a Chief Executive Officer at Zenios Bioscience LLP.
He is on the Board of Directors at Zura Bio Ltd.
Dr. Sidhu was previously employed as a Chairman & Chief Executive Officer by JATT Acquisition Corp.
and a Chief Business Officer by Pathios Therapeutics Ltd.
He received his undergraduate degree from Oxford University Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
6,64% | 31.12.2023 | 1 702 164 ( 6,64% ) | 27 Mio $ | 30.04.2024 |
ZURA BIO LIMITED CLASS A
8,43% | 22.04.2024 | 3 675 047 ( 8,43% ) | 13 Mio $ | 30.04.2024 |
Aktive Positionen von Someit Sidhu
| Unternehmen | Position | Beginn |
|---|---|---|
| ZURA BIO LIMITED | Gründer | 18.01.2022 |
Izana Bioscience Ltd.
 Izana Bioscience Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Izana Bioscience Ltd. is a British biotech company. The private company is based in London, UK. The company's website, izanabio.com, provides general information about the company. The company was founded in 2017 by Someit Sidhu. Someit Sidhu has been the CEO since 2017. | Vorstandsvorsitzender | 26.05.2017 |
| Akaza Bioscience Ltd. | Vorstandsvorsitzender | 01.01.2019 |
| Zenios Bioscience LLP | Vorstandsvorsitzender | - |
| JATT Ventures LP | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Someit Sidhu
| Unternehmen | Position | Ende |
|---|---|---|
Pathios Therapeutics Ltd.
 Pathios Therapeutics Ltd. BiotechnologyHealth Technology Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom. | Gründer | 28.08.2019 |
| JATT ACQUISITION CORP | Vorstandsvorsitzender | - |
Ausbildung von Someit Sidhu
| Oxford University Medical School | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZURA BIO LIMITED | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom. | Health Technology |
JATT Acquisition Corp.
 JATT Acquisition Corp. Financial ConglomeratesFinance JATT Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Someit Sidhu on March 10, 2021 and is headquartered in George Town, Cayman Islands. | Finance |
Izana Bioscience Ltd.
Izana Bioscience Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Izana Bioscience Ltd. is a British biotech company. The private company is based in London, UK. The company's website, izanabio.com, provides general information about the company. The company was founded in 2017 by Someit Sidhu. Someit Sidhu has been the CEO since 2017. | Health Technology |
| Akaza Bioscience Ltd. | |
| Zenios Bioscience LLP | |
| JATT Ventures LP |
